31. Cytoskeletal proteins as glioblastoma biomarkers and targets for therapyAlja Zottel, Ivana Jovchevska, Neja Šamec, Radovan Komel, 2021, review article Keywords: cytoskeleton, glioblastoma, biomarkers, glioblastoma therapy, vimentin, microtubules
Full text (file, 2,26 MB) This document has more files! More... |
32. Large-scale transcriptomics-driven approach revealed overexpression of CRNDE as a poor survival prognosis biomarker in glioblastomaMaxim Sorokin, Mikhail Raevskiy, Alja Zottel, Neja Šamec, Marija Skoblar Vidmar, Alenka Matjašič, Andrej Zupan, Jernej Mlakar, Maria Suntsova, Denis V. Kuzmin, Anton A. Buzdin, Ivana Jovchevska, 2021, original scientific article Keywords: glioblastoma, noncoding RNA, long-term survival, CRNDE, RNA sequencing
Full text (file, 4,17 MB) This document has more files! More... |
33. Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migrationAlja Zottel, Ivana Jovchevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, Radovan Komel, 2020, original scientific article Keywords: glioblastoma, glioblastoma stem cells, nanobodies, cell migration, cytotoxicity, vimentin, DPYSL2, NAP1L1, TUFM
Full text (file, 4,45 MB) This document has more files! More... |
34. Current technologies for RNA-directed liquid diagnosticsMaria Victoria Martinez-Dominguez, Alja Zottel, Neja Šamec, Ivana Jovchevska, Can Dincer, Ulf Dietrich Kahlert, Ann-Christin Nickel, 2021, review article Keywords: liquid biopsy, circulating free nucleic acids, exosome, cancer biomarker
Full text (file, 978,54 KB) This document has more files! More... |
35. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesiclesAlja Zottel, Neja Šamec, Ana Kump, Lucija Raspor Dall'Olio, Pia Pužar Dominkuš, Rok Romih, Samo Hudoklin, Jernej Mlakar, Daniil Nikitin, Maxim Sorokin, Anton A. Buzdin, Ivana Jovchevska, Radovan Komel, 2020, original scientific article Keywords: glioblastoma, biomarkers, exosomes, small extracellular vesicles, miRNA, miR-9-5p, miR-21-5p, miR-124-3p, miR-138-5p, vimentin
Full text (file, 2,88 MB) This document has more files! More... |
36. High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomasIvana Jovchevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A. Buzdin, Radovan Komel, 2019, original scientific article Keywords: glioblastoma, malignancy, FREM2, SPRY1, TCGA
Full text (file, 5,25 MB) This document has more files! More... |
37. Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidatesMarko Vidak, Ivana Jovchevska, Neja Šamec, Alja Zottel, Mirjana Liović, Damjana Rozman, Sašo Džeroski, Peter Juvan, Radovan Komel, 2018, original scientific article Keywords: glioblastoma, glioblastoma stem cells, biomarkers, data repositories, meta-analysis, cell surface, experimental validation, FREM2, SPRY1
Full text (file, 9,34 MB) This document has more files! More... |
|
39. Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivoAlja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovchevska, 2023, original scientific article Keywords: glioblastoma, vimentin, nanobody, invasion, EMT
Full text (file, 2,42 MB) This document has more files! More... |
|
